Basilea Pharmaceutica
Basilea Pharmaceutica AG, commonly referred to as Basilea, is a Swiss biopharmaceutical company headquartered in Basel, Switzerland. Founded in 2000, Basilea focuses on the development and commercialisation of innovative therapies for oncology and infectious diseases. The company has made significant strides in the pharmaceutical industry, particularly with its core products, which include advanced treatments for resistant infections and cancer. Basilea's unique approach combines cutting-edge research with a commitment to addressing unmet medical needs, positioning it as a key player in the global biopharmaceutical landscape. With a strong presence in Europe and North America, Basilea has achieved notable milestones, including successful product launches and strategic partnerships that enhance its market position. The company's dedication to innovation and patient care continues to drive its growth and reputation in the industry.
DitchCarbon Score
How does Basilea Pharmaceutica's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Basilea Pharmaceutica's score of 21 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Basilea Pharmaceutica's reported carbon emissions
Basilea Pharmaceutica, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years, as indicated by the absence of specific figures. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. While Basilea Pharmaceutica has not disclosed specific initiatives or targets, the industry trend suggests a growing emphasis on sustainability and environmental responsibility. As such, stakeholders may look forward to future commitments from the company regarding carbon emissions reduction and climate action strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Basilea Pharmaceutica is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
